Beta Bionics: Funding, Investors & Team (Oct 2026)
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analog with a unique stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community. Beta Bionics was founded in 2015 and is based in Boston, Massachusetts, United States.
Beta Bionics has raised $117M across 2 funding rounds on record, the most recent a Series E of $60.0M announced in Nov 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Beta Bionics Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Beta Bionics Funding Rounds
Beta Bionics raised $57.0M in a Series C announced in Feb 2022.
2.8 years later, a Series E of $60.0M was announced in Nov 2024.
Beta Bionics Founders and Leadership Team
Contact details for the Beta Bionics team: 2 of 2 have an email address on file.
Start 14-day free trial →Beta Bionics Funding Compared to Other Biotechnology Startups
Beta Bionics' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Beta Bionics in Biotechnology and Boston
Companies Similar to Beta Bionics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Beta Bionics Funding FAQs
What does Beta Bionics do?
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analog with a unique stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community. Beta Bionics was founded in 2015 and is based in Boston, Massachusetts, United States.
How much funding has Beta Bionics raised?
Beta Bionics has raised $117M across 2 rounds on record. The most recent is a Series E of $60.0M announced in Nov 2024.
When did Beta Bionics last raise funding?
Beta Bionics' most recent funding round on record is a Series E of $60.0M, announced in Nov 2024.
Who founded Beta Bionics?
FundedIQ lists Sean Saint (Founder) at Beta Bionics.
Who is the CEO of Beta Bionics?
Ed Damiano is listed as CEO at Beta Bionics.
Where is Beta Bionics headquartered?
Beta Bionics is based in Boston, Massachusetts, United States.
How many employees does Beta Bionics have?
Beta Bionics is in the 101-250 employee band.
How does Beta Bionics' funding compare to other Biotechnology startups?
Beta Bionics' latest round of $60.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Beta Bionics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beta Bionics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.